NOTICE: Labnodes will be unavailable on Sunday March 4th for scheduled maintenance from 6-11AM central time.
  1. Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. May ME, Srour A, Hedges LK, Lightfoot DA, Phillips JA, Blakely RD, Kennedy CH (2009) Am J Intellect Dev Disabil 114(4): 269-73
    › Primary publication · 19642709 (PubMed)
  2. Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. Veenstra-Vanderweele J, Jessen TN, Thompson BJ, Carter M, Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009) J Neurodev Disord 1(2): 158-71
    › Primary publication · 19960097 (PubMed) · PMC2786076 (PubMed Central)
  3. Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Carneiro AM, Airey DC, Thompson B, Zhu CB, Lu L, Chesler EJ, Erikson KM, Blakely RD (2009) Proc Natl Acad Sci U S A 106(6): 2047-52
    › Primary publication · 19179283 (PubMed) · PMC2632716 (PubMed Central)
  4. Enhanced activity of human serotonin transporter variants associated with autism. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009) Philos Trans R Soc Lond B Biol Sci 364(1514): 163-73
    › Primary publication · 18957375 (PubMed) · PMC2674096 (PubMed Central)
  5. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. English BA, Hahn MK, Gizer IR, Mazei-Robison M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD (2009) J Neurodev Disord 1(4): 252-63
    › Primary publication · 21547719 (PubMed) · PMC3164006 (PubMed Central)
  6. cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Steiner JA, Carneiro AM, Wright J, Matthies HJ, Prasad HC, Nicki CK, Dostmann WR, Buchanan CC, Corbin JD, Francis SH, Blakely RD (2009) Mol Brain : 26
    › Primary publication · 19656393 (PubMed) · PMC2731736 (PubMed Central)
  7. Targeting the human serotonin transporter (hSERT) with quantum dots. Tomlinson ID, Chang J, Iwamoto H, De Felice LJ, Blakely RD, Rosenthal SJ (2008) Proc SPIE Int Soc Opt Eng 6866(68660X): nihpa155701
    › Primary publication · 19936040 (PubMed) · PMC2779040 (PubMed Central)
  8. Quantum dot ex vivo labeling of neuromuscular synapses. Orndorff RL, Warnement MR, Mason JN, Blakely RD, Rosenthal SJ (2008) Nano Lett 8(3): 780-5
    › Primary publication · 18237149 (PubMed)
  9. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R (2008) Genes Brain Behav 7(4): 487-95
    › Primary publication · 18081710 (PubMed) · PMC2670227 (PubMed Central)
  10. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Carneiro AM, Cook EH, Murphy DL, Blakely RD (2008) J Clin Invest 118(4): 1544-52
    › Primary publication · 18317590 (PubMed) · PMC2260909 (PubMed Central)